Androgen Receptor (AR), E-Cadherin, and Ki-67 as Emerging Targets and Novel Prognostic Markers in Triple-Negative Breast Cancer (TNBC) Patients
about
High Levels of Nucleolar Spindle-Associated Protein and Reduced Levels of BRCA1 Expression Predict Poor Prognosis in Triple-Negative Breast Cancer.Prognostic value of reduced E-cadherin expression in breast cancer: a meta-analysis.Downregulation of androgen receptor is strongly associated with diabetes in triple negative breast cancer patients.The Correlation Between PARP1 and BRCA1 in AR Positive Triple-negative Breast Cancer.Ki-67 as a prognostic marker according to breast cancer molecular subtype.Caspase14 expression is associated with triple negative phenotypes and cancer stem cell marker expression in breast cancer patients.Androgen receptor-related diseases: what do we know?Prognostic value of androgen receptor expression in triple negative breast carcinomas: personal experience and comments on a review about "Triple-negative breast cancer: treatment challenges and solutions" by Collignon et alCorrection: Androgen Receptor (AR), E-Cadherin, and Ki-67 as Emerging Targets and Novel Prognostic Markers in Triple-Negative Breast Cancer (TNBC) Patients.The prognostic significance of combined androgen receptor, E-Cadherin, Ki67 and CK5/6 expression in patients with triple negative breast cancer.Prognostic Value of E-Cadherin and β-Catenin in Triple-Negative Breast Cancer.Duchesnea indica extract suppresses the migration of human lung adenocarcinoma cells by inhibiting epithelial-mesenchymal transition.Prognostic significance of CD117 expression and TP53 missense mutations in triple-negative breast cancer.E-cadherin breast tumor expression, risk factors and survival: Pooled analysis of 5,933 cases from 12 studies in the Breast Cancer Association Consortium.Clinical significance of androgen receptor expression in triple negative breast cancer-an immunohistochemistry study.The expression and clinical significance of GADD45A in breast cancer patients
P2860
Q35815004-340DC19B-9B5D-4A43-A20A-B8C2864BDDAFQ36266501-3456E4C3-371E-4AAB-BC66-E53EF6B5B668Q37228018-E32756A5-485F-4609-83C5-63E938A4BE16Q37513919-61C9010C-DFE0-49CF-A1AB-E4AC1CF56ABBQ37596690-1FDE10E1-63E8-437F-AF2D-2D562E225D1BQ38750783-09EEA17E-E51A-487D-ACB1-A84726D2A3EAQ38780007-7AB7FDD7-9B63-4DB9-B2BB-294D160125EDQ38942073-FFF4FC99-97A1-43BA-9B51-8B5E784859ACQ42369523-8D809E66-7FD7-4386-AE15-03BFE175A6C1Q46842412-1F40A8B9-FEBF-4BDB-9BBC-C5D7CE3E4BB0Q50560631-C6D2A583-E58C-4EF2-B7B8-ABBE0DE43E29Q51074577-27A3D622-8AA9-4266-9CA0-C2AA09304046Q55008104-A50ABF94-2471-4702-8317-A7DA4BB9D6ABQ55110745-89BDA275-CF85-41BA-8310-130E11E058FDQ55266544-51A9F9EE-7A10-4DA8-BCD7-8458B1333636Q58777790-ABB16906-83CF-4166-BAA8-D71C09A77711
P2860
Androgen Receptor (AR), E-Cadherin, and Ki-67 as Emerging Targets and Novel Prognostic Markers in Triple-Negative Breast Cancer (TNBC) Patients
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Androgen Receptor (AR), E-Cadh ...... Breast Cancer (TNBC) Patients
@ast
Androgen Receptor (AR), E-Cadh ...... Breast Cancer (TNBC) Patients
@en
type
label
Androgen Receptor (AR), E-Cadh ...... Breast Cancer (TNBC) Patients
@ast
Androgen Receptor (AR), E-Cadh ...... Breast Cancer (TNBC) Patients
@en
prefLabel
Androgen Receptor (AR), E-Cadh ...... Breast Cancer (TNBC) Patients
@ast
Androgen Receptor (AR), E-Cadh ...... Breast Cancer (TNBC) Patients
@en
P2093
P2860
P1433
P1476
Androgen Receptor (AR), E-Cadh ...... Breast Cancer (TNBC) Patients
@en
P2093
Barbara Adamo
Giovanni Tuccari
Giuseppa Ferraro
Giuseppina Rosaria Rita Ricciardi
Luana Licata
Roberta Cardia
Tindara Franchina
Vincenzo Adamo
P2860
P304
P356
10.1371/JOURNAL.PONE.0128368
P407
P50
P577
2015-06-03T00:00:00Z